uniQure Plans Reduction Of 28% Of Workforce Not Related To HEMGENIX Manufacturing Obligations; Total Cost Savings Of $180M To Extend Cash Runway Into Q2 Of 2027
Portfolio Pulse from Benzinga Newsdesk
uniQure announced plans to reduce its workforce by 28%, not including those committed to HEMGENIX manufacturing obligations. This equates to the elimination of 114 positions, or 20% of the total workforce. The company expects to save $180M, extending its cash runway into Q2 of 2027.
October 05, 2023 | 11:11 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
uniQure's workforce reduction is expected to save $180M, extending its cash runway into Q2 2027. This could potentially improve the company's financial stability.
The workforce reduction at uniQure is a significant move aimed at cost-saving. By eliminating 28% of its workforce, the company expects to save $180M, which will extend its cash runway into Q2 2027. This could potentially improve the company's financial stability and make it more attractive to investors, potentially driving up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100